Executive Summery

This report presents a detailed overview of the Viral Vector Manufacturing Market, highlighting key insights into its market size, share, and growth during the forecast period, i.e., 2024-30. It explores emerging trends, competitive dynamics, and the core drivers reshaping the industry. Backed by solid data and expert analysis, the study offers segment-wise insights and reliable forecasts to guide strategic decisions. With comprehensive market analysis and forward-looking perspectives, this report serves as a practical tool for stakeholders navigating change. Whether you're an investor, policymaker, or business leader, this research helps you stay ahead in the fast-evolving Viral Vector Manufacturing industry landscape.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Download your free sample PDF of the report– https://www.marknteladvisors.com/query/request-sample/viral-vector-manufacturing-market.html

Viral Vector Manufacturing Market Statistics and Key Highlights

The Global Viral Vector Manufacturing Market is estimated to grow at a CAGR of around 19.22% during the forecast period, i.e., 2024-30.

  • Viral Vector Manufacturing market shows steady growth
  • Market size expanding due to rising industry demand
  • Competitive landscape driven by tech and innovation
  • Detailed segment-wise and geography wise share analysis
  • Forecast reveals strong trends shaping future outlook

Key Player- Emerging Viral Vector Manufacturing Companies

  • Oxford Biomedica PLC
  • Charles River Laboratories
  • FUJIFILM Corporation
  • Lonza
  • Merck KGaA
  • Catalent, Inc.
  • AGC Biologics
  • Thermo Fisher Scientific Inc.
  • Vector BioMed
  • Biovian Oy
  • ReiThera srl
  • Curia Global, Inc.
  • Aurigene Pharmaceutical Services Ltd.
  • Revvity Inc.
  • SK Pharmteco Inc.

Access Full Market Insights & Key Statistics! https://www.marknteladvisors.com/research-library/viral-vector-manufacturing-market.html

Use your official business email to connect with our team and enjoy full access with priority support.

Key Driver:

Increased Burden of Genetic Disorders – During the past few years, there has been a significant surge in the number of genetic disorders globally. Among them, there has been a significant rise in the number of patients with hemophilia. For instance, the World Federation of Hemophilia (WFH) reported a global count of approximately 257,146 individuals diagnosed with the condition in 2022. Specifically, hemophilia A and B cases were recorded at 208,957 and 42,203, respectively. This surge in instances of hemophilia has resulted in an amplified demand for gene therapy for treatment purposes. Thus, this demand has consequently driven the need for viral vectors, essential for delivering gene therapy, thereby accelerating growth in the Viral Vector Manufacturing Market.

Additionally, the rising prevalence of other genetic blood disorders, notably sickle-cell disease and thalassemia, has further fueled market growth. According to the World Health Organization (WHO), approximately 5% of the global population carries trait genes for hemoglobin disorders, predominantly sickle-cell disease and thalassemia. Furthermore, increasing awareness and initiatives by government and non-governmental organizations aimed at educating the public about these genetic disorders and facilitating their diagnosis and treatment are contributing to the increased number of diagnosed patients who require therapies. 

Looking for Global, Regional or country-specific reports on this market?

Visit our website or simply fill out the inquiry form, and our team will reach out with customized insights and support -  https://www.marknteladvisors.com/query/request-customization/viral-vector-manufacturing-market.html

Viral Vector Manufacturing Market Segmentation

By Vector Type

  • Adenoviral Vector- Market Size & Forecast 2019-2030, USD Million
  • Adeno-Associated Viral Vector- Market Size & Forecast 2019-2030, USD Million
  • Lentiviral Vector- Market Size & Forecast 2019-2030, USD Million
  • Herpes Simplex Viral-Vector- Market Size & Forecast 2019-2030, USD Million
  • Retroviral Vector- Market Size & Forecast 2019-2030, USD Million
  • Others (CMV, HSV-1, Vaccina, etc.)- Market Size & Forecast 2019-2030, USD Million

By Application

  • Gene Therapy- Market Size & Forecast 2019-2030, USD Million
  • Cell Therapy- Market Size & Forecast 2019-2030, USD Million
  • Vaccines- Market Size & Forecast 2019-2030, USD Million
    • Non-Replicating Viral Vector Vaccines- Market Size & Forecast 2019-2030, USD Million
    • Replicating Viral Vector Vaccines- Market Size & Forecast 2019-2030, USD Million

By Indication

  • Genetic Disorders- Market Size & Forecast 2019-2030, USD Million
    • Hemophilia- Market Size & Forecast 2019-2030, USD Million
    • Sickle Cell Disease- Market Size & Forecast 2019-2030, USD Million
    • Duchenne muscular dystrophy- Market Size & Forecast 2019-2030, USD Million
    • Beta-Thalassemia- Market Size & Forecast 2019-2030, USD Million
    • Spinal Muscular Atrophy (SMA)- Market Size & Forecast 2019-2030, USD Million
    • Others (inherited retinal disorder, cerebral adrenoleukodystrophy (CALD, severe combined immunodeficiency due to adenosine deaminase deficiency)-   Market Size & Forecast 2019-2030, USD Million
  • Cancer- Market Size & Forecast 2019-2030, USD Million
    • Bladder Cancer- Market Size & Forecast 2019-2030, USD Million
    • Blood Cancer- Market Size & Forecast 2019-2030, USD Million
    • Head & Neck Cancer- Market Size & Forecast 2019-2030, USD Million
  • Infectious Diseases- Market Size & Forecast 2019-2030, USD Million
    • COVID-19- Market Size & Forecast 2019-2030, USD Million
    • Ebola Virus- Market Size & Forecast 2019-2030, USD Million
    • Malaria- Market Size & Forecast 2019-2030, USD Million

By Scale of Operation

  • Pre-Clinical- Market Size & Forecast 2019-2030, USD Million
  • Clinical- Market Size & Forecast 2019-2030, USD Million
  • Commercial- Market Size & Forecast 2019-2030, USD Million

By End User

  • Biotech Companies- Market Size & Forecast 2019-2030, USD Million
  • Pharmaceutical Companies- Market Size & Forecast 2019-2030, USD Million
  • Research Organizations- Market Size & Forecast 2019-2030, USD Million

By Region

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

North America accounted for the largest share of the Global Viral Vector Manufacturing Market.

Reasons to Buy This Report

  1. Gain comprehensive insights into current market trends and dynamics.
  2. Equip your business with data-driven strategies for informed decisions.
  3. Identify lucrative market opportunities and strategic growth areas.
  4. Analyze competitors to enhance your positioning in the market landscape.
  5. Understand geographical trends across diverse markets for better expansion strategies.

Other reports

About US:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us:

MarkNtel Advisors LLP

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

For Sales Enquiries: [email protected]